Rebiotix

In the Know: Healthcare News for May 26, 2020

Lee Jones Selected University of Minnesota Entrepreneur of the Year Medtronic, Abbott, Thermo Fisher Are The World’s Largest Healthcare Companies In 2020 Med-tech company Tactile Medical announces new CEO Corporate America’s Most Underrated Innovation Strategy: 3M’s 15% Rule Medtronic execs see quick recovery, increased M&A NaviHealth trades hands again with Optum acquisition DeviceTalks Weekly: EP. […]

In the Know: Healthcare News for May 11, 2020

Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy RBX2660 3M completes $650M drug delivery unit sale, but business to remain in Twin Cities Predictive Oncology Initiates $2.2M Direct Stock Offering Study tests revolutionary treatments for depression The Lacek Group Expands Healthcare Practice and Joins Medical Alley […]

Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy RBX2660

Rebiotix and Ferring are the first to announce positive preliminary results on primary efficacy endpoint from ongoing pivotal Phase 3 clinical trial for RBX2660 RBX2660 is an investigational, non-antibiotic, microbiome-based therapy, developed to reduce Clostridiodes difficile (C. diff) infection recurrences CDC defines C. diff as a major burden to patients and doctors and an urgent […]

In The Know: Healthcare News for February 10, 2020

Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’S Breakthrough Device Designation Mayo Clinic again receives top honors for high-quality patient care Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal […]

Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660

Enrollment completion for the first Phase 3 clinical trial in microbiome industry Largest randomized, double-blinded study, with over 300 patients enrolled aimed to demonstrate the potential benefit of RBX2660 in reducing rates of recurrent Clostridioides difficile (C. diff) infection Rebiotix intends to use the results from the Phase 3 trial to serve as the basis […]

In the Know: Healthcare News for October 14, 2019

Phase 2 Results: Microbiota-Based RBX2660 Safe, Efficacious for Preventing C diff Recurrence Medtronic Bids for FDA Approval of OAB/FI Neuromodulation Device – MassDevice Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta This Is the Strongest Pipeline in Medtronic’s History Funding Roundup: 4C Medical Spineology Seek Millions West Monroe […]

In the Know: Healthcare News for September 2, 2019

Medical Alley Association’s Statement on the Upcoming Retirement of Medtronic CEO Omar Ishrak UnitedHealthcare launches new UnitedHealthcare Hearing vertical Minnesota Blues strikes up outcomes-based cancer care arrangement Mayo’s Q2 income soars Medtronic Drops Huge Update on Surgical Robotics System Smiths Medical announces partnership with Medline Industries, Inc Abbott touts potential of 15-minute concussion detection ZOLL […]

In the Know: Healthcare News for August 19, 2019

Fairview acquires Wisconsin-based Vibrant Health AtriCure offers $300m for SentreHeart Bio-Techne: $50m reagent plant support cell & genes Mayo Clinic invests in breast cancer imaging AI We’re Starting to Harness the Microbiome to Treat Disease Despite a Cold M&A Market in Minnesota, Deal Activity in Healthcare Remains Hot UK regulators OK Boston Scientific’s $4B BTG […]

In the Know: Healthcare News for July 15, 2019

Boston Scientific plans for 75 new products by 2022 Top US hospital opens London clinic offering £5k ‘health MoTs’ Reprise Biomedical Raises $12.5 Million and Completes Spin-Off From Miromatrix Medical UnitedHealth Group Invests In Job Of The Future: ‘Data Scientists’ 6 MAA Members Make Forbes’ List of Best Employers for Women Joan Gabel takes helm […]

Angel Tax Credit Program Reopens; Medical Alley Applauds Minnesota’s Return to an Early-Stage Growth Agenda

Minneapolis, MN – Medical Alley Association is thrilled to announce that starting July 1, 2019 the Minnesota Department of Employment and Economic Development (DEED) will be accepting applications for the newly-reenacted Angel Tax Credit Program. Medical Alley Association thanks Senator Paul T. Anderson and Representative Carlie Kotyza-Witthuhn for authoring this bill, as well as Governor […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER